Pharma Journalist - Page 102 of 937 -

Arcturus Partners With Thermo Fisher on Cystic Fibrosis mRNA Therapy

Lonza Secures Nona’s BBB Technology for CNS Drug Development

Ipsen Acquires Memo Therapeutics to Advance BK Virus Treatment

Kazia Therapeutics Launches Groundbreaking Trial of Paxalisib and Immunotherapy for Advanced Breast Cancer

Orion and Invenra Partner to Develop Bispecific Antibody Cancer Therapies

ImmunityBio Partners with BeiGene on Phase 3 Trial for ANKTIVA and PD-1 Combo in NSCLC

European Commission Approves ViiV’s Vocabria + Rekambys for HIV Treatment in Adolescents

FDA Approves LEQEMBI IV Maintenance Dosing for Early Alzheimer’s Disease

FDA Grants Priority Review to Merck’s WELIREG for Advanced Pheochromocytoma and Paraganglioma

Pfizer’s BRAFTOVI Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

AstraZeneca to Invest C$820M in Canada to Expand Global Hub and Clinical Delivery

AbbVie and Neomorph Partner to Develop Molecular Glue Degraders for Oncology and Immunology

Lupin Receives U.S. FDA Approval for Sacubitril and Valsartan Tablets